Defence Therapeutics Inc. (DTCFF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.28 Million | -7.65 Million | -6.04 Million | -2.28 Million | -132.82 Thousand | -3147.00 |
| Net Income | -13.19 Million | -6.76 Million | -7.34 Million | -2.85 Million | -673.18 Thousand | -1946.00 |
| Depreciation & Amortization | 90.92 Thousand | 13.82 Thousand | - | - | - | - |
| Deferred income taxes | - | -105 Thousand | - | - | - | - |
| Stock-based compensation | 5.83 Million | 295.17 Thousand | 371.27 Thousand | 606.01 Thousand | 179.98 Thousand | - |
| Change in working capital | 2.57 Million | -1.36 Million | 928.33 Thousand | -36.41 Thousand | 47.51 Thousand | -6999.00 |
| Other non-cash items | 397.85 Thousand | 707.6 Thousand | 327.4 Thousand | 677.64 Thousand | 312.85 Thousand | 5798.00 |
| Investing Cash Flow | -203.23 Thousand | -65.8 Thousand | - | - | -46.01 Thousand | - |
| Investments in PPE | -203.23 Thousand | -65.8 Thousand | - | - | -46.01 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -46.02 | - |
| Financing Cash Flow | 1.75 Million | 10 Million | 1.09 Million | 5.87 Million | 2.04 Million | - |
| Debt repayment | -26.73 Thousand | -2.34 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.88 Million | 7.85 Million | 1.09 Million | 2.75 Million | 2.27 Million | - |
| Other Financing Activities | -124.6 Thousand | -197.78 Thousand | 1098.19 | 3.11 Million | -232.99 Thousand | - |
| Accounts receivables | 53.08 Thousand | -121.84 Thousand | 43.86 Thousand | -71.62 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.52 Million | -1.23 Million | 884.46 Thousand | 35.21 Thousand | 47.51 Thousand | -6999.00 |
| Cash at beginning of period | 2.79 Million | 506.69 Thousand | 5.45 Million | 1.86 Million | 766.00 | 3913.00 |
| Cash at end of period | 56.54 Thousand | 2.79 Million | 506.69 Thousand | 5.45 Million | 1.86 Million | 766.00 |
| Capital Expenditure | -203.23 Thousand | -65.8 Thousand | - | - | -46.01 Thousand | - |
| Effect of forex changes on cash | - | -2.28 Million | - | - | - | - |
| Net cash flow / Change in cash | -2.73 Million | 2.28 Million | -4.94 Million | 3.58 Million | 1.86 Million | -3147.00 |
| Free Cash Flow | -4.49 Million | -7.72 Million | -6.04 Million | -2.28 Million | -178.84 Thousand | -3147.00 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.34 Million | -1.32 Million | -8.31 Million | -2.19 Million | -1.72 Million | -6.76 Million |
| Depreciation & Amortization | 48.63 Thousand | 22.55 Thousand | 6948.00 | 12.78 Thousand | 789.00 | 13.82 Thousand |
| Deferred income taxes | - | - | -5.86 Million | - | -105 Thousand | -105 Thousand |
| Stock-based compensation | - | - | 5.83 Million | - | - | 295.17 Thousand |
| Change in working capital | 618.46 Thousand | 269.42 Thousand | 1.02 Million | 666.75 Thousand | -419.18 Thousand | -1.36 Million |
| Other non-cash items | 148.96 Thousand | 94.85 Thousand | 5.92 Million | 95.95 Thousand | 166.29 Thousand | 707.6 Thousand |
| Investing Cash Flow | 16.94 Thousand | -213.68 Thousand | - | -6500.00 | -5033.00 | -65.8 Thousand |
| Investments in PPE | 16.94 Thousand | -213.68 Thousand | - | -6500.00 | -5033.00 | -65.8 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 57.24 Thousand | 1.31 Million | 394.51 Thousand | -14.66 Thousand | 2.06 Million | 10 Million |
| Debt repayment | -42.24 Thousand | -28.38 Thousand | -21.47 Thousand | -14.66 Thousand | - | -2.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15 Thousand | 1.45 Million | 423.75 Thousand | - | 2.06 Million | 7.85 Million |
| Other Financing Activities | 65.00 | 1.32 Million | -7756.00 | - | 1.00 | -197.78 Thousand |
| Accounts receivables | -35.93 Thousand | 12.4 Thousand | -12.46 Thousand | 89.07 Thousand | -61.22 Thousand | -121.84 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 654.39 Thousand | 257.01 Thousand | 1.03 Million | 577.67 Thousand | -357.95 Thousand | -1.23 Million |
| Cash at beginning of period | 514.52 Thousand | 350.99 Thousand | 1.35 Million | 2.79 Million | 2.87 Million | 506.69 Thousand |
| Cash at end of period | 56.54 Thousand | 514.52 Thousand | 350.99 Thousand | 1.35 Million | 2.79 Million | 2.79 Million |
| Capital Expenditure | 16.94 Thousand | -213.68 Thousand | - | -6500.00 | -5033.00 | -65.8 Thousand |
| Effect of forex changes on cash | - | - | - | - | 1.00 | -2.28 Million |
| Net cash flow / Change in cash | -457.98 Thousand | 163.53 Thousand | -999.11 Thousand | -1.44 Million | -84.76 Thousand | 2.28 Million |
| Free Cash Flow | -515.22 Thousand | -1.15 Million | -1.39 Million | -1.42 Million | -2.15 Million | -7.72 Million |
NNH
000591
LUC
SGGKF
RFLXF
LLN